Net patient service revenues for the quarter increased by $4.8 million, or 61%, from $7.8 million in 2006 to $12.6 million in 2007. The Company’s Garland Facility had an increase in both bariatric and orthopedic cases due to recruitment of additional physicians. Income from continuing operations was $2.6 million for the third quarter in 2007 compared to a loss from continuing operations of $0.4 million in 2006’s third quarter. Net income was $2.6 million in 2007’s third quarter, or $0.17 per share, versus net loss of $0.8 million, or $0.05 per share, in 2006’s third quarter.
Net patient service revenues for the nine months ended May 31, 2007 increased by $6.0 million, or 23%, from $25.8 million in 2006 to $31.8 million in 2007. Income from continuing operations for the nine months ended May 31, 2007 was $1.7 million, or $0.11 per share, versus loss from continuing operations of $1.6 million, or $0.11 per share, in the same period in 2006. Net income was $0.6 million, or $0.04 per share, for the nine months ended May 31, 2007 versus net loss of $4.7 million, or $0.31 per share, for the same period in 2006.
Dynacq Healthcare, Inc. ("www.dynacq.com") is a holding company.
Its subsidiaries provide surgical healthcare services and related
ancillary services through hospital facilities and an outpatient
Certain statements included in this press release, which are not
historical facts, are forward-looking statements. Such forward-looking
statements are made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. These
forward-looking statements represent our expectations or beliefs,
intentions, future events, future performance, business prospects and
involve certain risks and uncertainties, including those described in
our public filings with the United States Securities and Exchange
Commission, also including, but not limited to, changes in interest
rates, competitive pressures, changes in customer mix, changes in
third party reimbursement rates, financial stability of major
customers, changes in government regulations or the interpretation of
these regulations, changes in supplier relationships, growth
opportunities, cost savings, revenue enhancements, synergies and other
benefits anticipated from acquisition transactions, difficulties
relative to integrating acquired business, the accounting and tax
treatments of acquisitions, and asserted and unasserted claims, which
could cause actual results to differ materially from those indicated
in the forward-looking statements. The forward-looking statements by
their nature involve substantial risks and uncertainties, certain of
which are beyond our control, and actual results may differ materially
depending on a variety of important factors. You are cautioned not to
place undue reliance on these forward-looking statements that speak
only as of the date herein. The risks and uncertainties that may cause
these forward-looking statements to prove to be incorrect include,
without limitation, adverse effects of litigation or regulatory
actions, inability to negotiate desired terms with proposed joint
venture partners, and favorable regulatory determinations for
availability of financing options and other transactions.
Dynacq Healthcare, Inc., Houston
Philip S. Chan, 713-378-2000
Dynacq Healthcare, Inc.